First-line Helicobacter pylori Eradication with Vonoprazan, Amoxicillin, and Metronidazole for university students
Not Applicable
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000032105
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) A patient with history of Helicobacter pylori eradication. (2) Patients allergic to penicillin. (3) Past history of allergy for the drugs used in this study. (4) Pregnancy. (5) Lactation. (6) A patient with brain and spinal cord disease. (7) A patient with infectious mononucleosis. (8) Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction. (9) Patient who is disqualified for the study by physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rate assessed by stool antigen test of Helicobacter pylori more than 8 weeks after treatment
- Secondary Outcome Measures
Name Time Method Adverse event evaluated by side effect questionnaire filled by patients